Benjamin Davis
Impact in
- Virology top 5%
- Rabies epidemiology and control
- Immunology top 10%
- Immunotherapy and Immune Responses
- interferon and immune responses
- Immune responses and vaccinations
Papers in
-
- SARS-CoV-2 and COVID-19 Research 2
- Clostridium difficile and Clostridium perfringens research 1
- Viral Infections and Vectors 1
- Viral Infections and Outbreaks Research 1
- Virology 2
- Rabies epidemiology and control 2
- Co-authors
- Matthias J. Schnell (3 shared papers)Glenn F. Rall (1 shared paper)Jianhong Lu (1 shared paper)Gordon T. Ruthel (1 shared paper)Yuliang Liu (1 shared paper)Allen B. Reitz (1 shared paper)Jay E. Wrobel (1 shared paper)Mark A. Olson (1 shared paper)
- Journals
- Journal of Virology (2 papers)Molecular Genetics and Metabolism (1 paper)Nature Communications (1 paper)Annual Review of Virology (1 paper)npj Vaccines (1 paper)
- Partner nations
- United StatesCanadaThailand
In The Last Decade
Benjamin Davis
9 papers receiving 894 citations
Benjamin Davis's Hit Papers
Peers
Comparison fields: 5 of 68
- Virology 130
- Immunology 259
- Infectious Diseases 203
- Molecular Biology 312
- Pharmaceutical Science 21
Countries citing papers authored by Benjamin Davis
This map shows the geographic impact of Benjamin Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Davis more than expected).
Fields of papers citing papers by Benjamin Davis
This network shows the impact of papers produced by Benjamin Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Davis. The network helps show where Benjamin Davis may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Davis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses Hit paper breakdown → | 2021 | 592 |
| 2 | 2015 | 133 | |
| 3 | 2014 | 87 | |
| 4 | A multivalent mRNA-LNP vaccine protects against Clostridioides difficile infection Hit paper breakdown → | 2024 | 62 |
| 5 | 2017 | 36 | |
| 6 | 2025 | 9 | |
| 7 | 2022 | 2 | |
| 8 | 2025 | 1 | |
| 9 | 2026 | 1 |
About Benjamin Davis
Benjamin Davis is a scholar working on Infectious Diseases, Virology, Immunology, Epidemiology and Radiology, Nuclear Medicine and Imaging, having authored 9 papers that have together received 923 indexed citations. Recurring topics across this work include Rabies epidemiology and control (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), RNA Interference and Gene Delivery (1 paper), Clostridium difficile and Clostridium perfringens research (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper), Viral Infections and Vectors (1 paper), Viral Infections and Outbreaks Research (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Virology (130 citations), Immunology (259 citations), Infectious Diseases (203 citations), Molecular Biology (312 citations) and Pharmaceutical Science (21 citations). Benjamin Davis has collaborated with scholars based in United States, Canada and Thailand. Frequent co-authors include Matthias J. Schnell, Glenn F. Rall, Jianhong Lu, Gordon T. Ruthel, Yuliang Liu, Allen B. Reitz, Jay E. Wrobel, Mark A. Olson, Bruce D. Freedman and Ziying Han. Their work appears in journals such as Journal of Virology, Molecular Genetics and Metabolism, Nature Communications, Annual Review of Virology and npj Vaccines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.